Appendix C

Statement of Task

An ad hoc planning committee will plan and conduct a public workshop to discuss research methodologies related to demonstrating and assessing the clinical validity and clinical utility of molecular diagnostics that are used to guide treatment and management of oncology patients. The goal of the workshop will be to advance discussions among a broad array of stakeholders, including patients, providers, policy makers, payers, test developers, guideline developers, and others, around evidence needs for informed clinical and health policy decision making. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually authored summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures. This workshop will be held jointly with the Center for Medical Technology Policy.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 95
Appendix C Statement of Task An ad hoc planning committee will plan and conduct a public work- shop to discuss research methodologies related to demonstrating and assess- ing the clinical validity and clinical utility of molecular diagnostics that are used to guide treatment and management of oncology patients. The goal of the workshop will be to advance discussions among a broad array of stake- holders, including patients, providers, policy makers, payers, test develop- ers, guideline developers, and others, around evidence needs for informed clinical and health policy decision making. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually authored summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures. This workshop will be held jointly with the Center for Medical Technology Policy. 95

OCR for page 95